Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A M Raaijmakers

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics and the pharmaceutical industryJan A M Raaijmakers, Ellen S Koster, Anke-Hilse Maitland-van der Zee
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Rapid selective priming of FcalphaR on eosinophils by corticosteroidsWillem ten Hove, Leo A Houben, Jan A M Raaijmakers, et al.
Molecular Immunology|November 28, 2006
Differential regulation of TNFalpha and GM-CSF induced activation of P38 MAPK in neutrophils and eosinophilsWillem ten Hove, Leo A Houben, Jan A M Raaijmakers, et al.
International Journal of Clinical Pharmacy|January 31, 2012
Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment earlyTanja T Menckeberg, Jacqueline G Hugtenburg, Jan Willem Lammers, et al.
Pharmacogenomics|June 18, 2009
Systems biology in pharmacogenomic research: the way to personalized prescribing?Ellen S Koster, Andrei S Rodin, Jan A M Raaijmakers, et al.
Pharmacoepidemiology and Drug Safety|September 29, 2011
Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort studyEllen S Koster, Jan A M Raaijmakers, Susanne J H Vijverberg, et al.
British Journal of Clinical Pharmacology|August 23, 2008
Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroidsTanja T Menckeberg, Marcel L Bouvy, Madelon Bracke, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 18, 2015
[Threshold value for reimbursement of costs of new drugs: cost-effectiveness research and modelling are essential links]Geert W J Frederix, Anke M Hövels, Johan L Severens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomesGerardus W J Frederix, Johan L Severens, Anke M Hövels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
The cloudy crystal ball of cost-effectiveness studiesGerardus W J Frederix, Johan L Severens, Anke M Hövels, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Design|March 9, 2010
Pharmacogenetics and the pharmaceutical industryJan A M Raaijmakers, Ellen S Koster, Anke-Hilse Maitland-van der Zee
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Rapid selective priming of FcalphaR on eosinophils by corticosteroidsWillem ten Hove, Leo A Houben, Jan A M Raaijmakers, et al.
Molecular Immunology|November 28, 2006
Differential regulation of TNFalpha and GM-CSF induced activation of P38 MAPK in neutrophils and eosinophilsWillem ten Hove, Leo A Houben, Jan A M Raaijmakers, et al.
International Journal of Clinical Pharmacy|January 31, 2012
Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment earlyTanja T Menckeberg, Jacqueline G Hugtenburg, Jan Willem Lammers, et al.
Pharmacogenomics|June 18, 2009
Systems biology in pharmacogenomic research: the way to personalized prescribing?Ellen S Koster, Andrei S Rodin, Jan A M Raaijmakers, et al.
Pharmacoepidemiology and Drug Safety|September 29, 2011
Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort studyEllen S Koster, Jan A M Raaijmakers, Susanne J H Vijverberg, et al.
British Journal of Clinical Pharmacology|August 23, 2008
Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroidsTanja T Menckeberg, Marcel L Bouvy, Madelon Bracke, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 18, 2015
[Threshold value for reimbursement of costs of new drugs: cost-effectiveness research and modelling are essential links]Geert W J Frederix, Anke M Hövels, Johan L Severens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomesGerardus W J Frederix, Johan L Severens, Anke M Hövels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
The cloudy crystal ball of cost-effectiveness studiesGerardus W J Frederix, Johan L Severens, Anke M Hövels, et al.
Pageof 4